1YASUHIRO H,PETER J F.Stent thrombosis:an issue revisited in a changing world[J].Circulation,2003,108:2-5.
2REYNOLDS M R,RINALDI M J,PINTO D S,et al.Current clinical characteristics and economic impact of subacute stent thrombosis[J].J Invasive Cardiol,2002,14:364-368.
3CHENEAU E,LEBORGNE L,MINTZ G S,et al.Predictors of subacute stent thrombosis:results of a systemic intravascular ultrasound study[J]:Circulation,2003,108:43-47.
4SILVA J A,RAMEE S R,WHITE C J,et al.Primary stenting in acute myocardial infarction:influence of diabetes mellitus in angiographic results and clinical outcome[J].Am Heart J,1999,138:446-455.
5WALTER D H,SCHACHINGER V,ELSNER M,et al.Platelet glycoprotein Ⅲa polymorphisms and risk of coronary stent thrombosis[J].Lancet,1997,350:1217-1219.
4[3]Helton E,Durragh R,Francis P,et al.Metabolic aspects of myocardial disease and a role of L-carnitine in the treatment of children cardiomyo-pathy.Pediatrics,2000,105:1260
5[5]Yamadaka,Kanterem,NewatiaaA.Longchain acylcarnitine induces Ca2 efflux from the sarco-plasmic reticulum.JCardiovasc Pharmacol,2000,36(1):14221
6[6]Netticadant,Yul,Dhallans,etal.Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes.JMol Cell Cardiol,1999,31(7):135721367
7[7]Baetzd,Bernardm,Pinetc,etal.Different pathways for sodium entry in cardiac cells during ischemia and early reperfusion.Mol Cell Biochem,2003,242(122):1152120
8[8]Kashiwagi A,Kanno T,Arita K,etal,Suppression of T(3)-and fatty acid-induced membrane permeability transition by L-carnitine.Comp Biochem physio1 B,Biochem Mo1 Biol,2001,130(3):411
9[9]Colonmna P,Lliceto S,Myocardial infarction and left ventriculuar remodeling;remodeling results of the CEDIM trial,Carnitine Ecocardiografia Digitalizzata Infarto Miocardico.AM Heart J,2000,139:s124
10[11]Feidman LJ,Coate P,Ferer A,et al.WFrench optimal Stenting 2 Invest.Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction afrer stenting for acute myocardial infarcton.Circulation,2003,107:2684
